Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Fe.3HO |
| Molecular Weight | 106.867 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[OH-].[OH-].[OH-].[Fe+3]
InChI
InChIKey=MSNWSDPPULHLDL-UHFFFAOYSA-K
InChI=1S/Fe.3H2O/h;3*1H2/q+3;;;/p-3
| Molecular Formula | Fe |
| Molecular Weight | 55.845 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103&#v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlCurator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Sources: https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103&#v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.html
Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Ferric Ammonium EDTA Solution is normally used as a photographic chemical for a bleaching agent in the process of colour washing. It is also used as a complexing, and oxidizing agent & as a fertilizer and catalyst. EDTA acid are colourless, water-soluble solid that are widely used to dissolve scale. The usefulness of these ammonium salts arise because of its role as a chelating agent, i.e. its ability to "sequester" metal ions such as Ca2+ and Fe3+.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006927 |
|||
Target ID: CHEMBL2364184 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | SANFEROL Approved UseIt has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency. |
|||
| Inactive ingredient | Oxycontin Approved UseOxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Launch Date1998 |
|||
| Palliative | AURYXIA Approved UseFerric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date2014 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Phosphorus recovery from biogas slurry by ultrasound/H2O2 digestion coupled with HFO/biochar adsorption process. | 2017-02 |
|
| Superior electrochemical performance of N-doped nanocrystalline FeF3/C with a single-step solid-state process. | 2016-10-04 |
|
| Heme Binding by Corynebacterium diphtheriae HmuT: Function and Heme Environment. | 2015-11-03 |
|
| Microwave assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products. | 2014-08-26 |
|
| FeF(3) catalyzed cascade C-C and C-N bond formation: synthesis of differentially substituted triheterocyclic benzothiazole functionalities under solvent-free condition. | 2014-05 |
|
| Finnish wallpaper pigments in the 18th-19th century: presence of KFe3(CrO4)2(OH)6 and odd pigment mixtures. | 2013-04 |
|
| Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions. | 2011-06 |
|
| Fabrication of FeF3 Nanoflowers on CNT branches and their application to high power lithium rechargeable batteries. | 2010-12-07 |
|
| Interaction of omapatrilat with FD&C Blue No. 2 lake during dissolution of modified release tablets. | 2007-07-18 |
|
| Non-invasive and non-destructive micro-XRF and micro-Raman analysis of a decorative wallpaper from the beginning of the 19th century. | 2007-02 |
|
| New phosphate binding agents: ferric compounds. | 1999-06 |
|
| Effect of physical exercise and vitamin C on absorption of ferric sodium citrate. | 1996-12 |
|
| Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. | 1989 |
|
| Contact dermatitis to yellow iron oxide. | 1985-08 |
|
| Biological availability of iron supplements for rats, chicks and humans. | 1976-02 |
|
| The absorption of iron as supplements in infant cereal and infant formulas. | 1975-05 |
|
| The formation of ferritin from apoferritin. Catalytic action of apoferritin. | 1973-10 |
|
| The formation of ferritin from apoferritin. Kinetics and mechanism of iron uptake. | 1972-01 |
|
| [Effects of ferric fluoride compounds on dental enamel]. | 1954-11-15 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
Unknown
Route of Administration:
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:19:39 GMT 2025
by
admin
on
Mon Mar 31 18:19:39 GMT 2025
|
| Record UNII |
2UA751211N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B03AB04
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
||
|
WHO-VATC |
QB03AB04
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000078937
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
C83713
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
73964
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
DB13423
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
C021024
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
1428835
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | RxNorm | ||
|
SUB13843MIG
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
ALTERNATIVE | |||
|
1309-33-7
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
2UA751211N
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
11113-66-9
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
ALTERNATIVE | |||
|
Ferric hydroxide
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
215-166-1
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
DTXSID5051652
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
4539
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
SUB13842MIG
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY | |||
|
234-346-0
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
ALTERNATIVE | |||
|
CHEMBL3707285
Created by
admin on Mon Mar 31 18:19:39 GMT 2025 , Edited by admin on Mon Mar 31 18:19:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |